Gender-Based Analysis of the 3-Year Outcome of Bioactive Stents Versus Paclitaxel-Eluting Stents in Patients with Acute Myocardial Infarction: An Insight from the TITAX-AMI Trial

Author(s): 

Petri O. Tuomainen, MD, PhD1, Antti Ylitalo, MD, PhD2, Matti Niemelä, MD, PhD3, Kari Kervinen, MD, PhD3, Mikko Pietilä, MD, PhD4, Jussi Sia, MD5, Kai Nyman, MD6, Wail Nammas, MD, PhD2, K.E. Juhani Airaksinen, MD, PhD4, Pasi P. Karjalainen, MD, PhD2



Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.